Mountain View, California Clinical Trials

A listing of Mountain View, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
Peer-Led Dissonance Eating Disorder Prevention: Virtual Delivery

This proposed pilot study will evaluate whether this body acceptance class produces greater reductions in eating disorder risk factor symptoms (pursuit of the thin ideal, body dissatisfaction, dieting, dietary restraint and negative affect), eating disorder symptoms, and future onset of eating disorders over 6-month follow-up in this population.

disordered eating
disorder prevention
eating disorder
Stanford University School of Medicine
 (5.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

lung disease
headache
chronic obstructive pulmonary disease
cough
malaise
Stanford University Hospital
 (5.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

multicentric castleman disease
gemcitabine
stage ii lung squamous cell carcinoma ajcc v7
squamous cell carcinoma
pd-l1
Palo Alto Medical Foundation-Camino Division
 (0.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +358 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

critical illness
mechanical ventilation
critically ill
dexamethasone
intrauterine device (iud)
Coronavirus Research Institute-Testing Site
 (3.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
Optimal Timing of BR55 CEUS of the Ovaries

This is an exploratory, single center, open label, prospective study of BR55 to determine the optimal phase of the menstrual cycle for performing BR55 CEUS of the target ovary in premenopausal women scheduled to undergo preventative surgery because of high familial/hereditary or genetic risk for ovarian cancer.

oophorectomy
systemic therapy
ovarian cancer
major surgery
hypertension
Stanford University Medical Center
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
HDR Brachytherapy 68-Ga-RM2 PET 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

This study is being conducted to determine whether the combination of imaging agents 68-Ga RM2 and 68-Ga PMSA11 is better at assessing response to high dose rate (HDR) local therapy than standard imaging or biopsy in patients with known prostate cancer (PC)

pet/mri
brachytherapy
local therapy
Stanford Cancer Center
 (5.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for …

major depressive disorder
depressive disorder
Stanford University
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

graft versus host disease
recurrent ewing sarcoma
rhabdomyosarcoma recurrent
recurrent osteosarcoma
seizure disorder
Lucile Packard Children's Hospital Stanford University
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

The purpose of the research is to evaluate whether both chemotherapy and radiotherapy can lead to higher rates of clinical complete response leading to organ preservation in human subjects with cancer. The objective is to learn if this treatment approach may safely be used as an alternative to the standard …

organ preservation
folfox regimen
adenocarcinoma of rectum
absolute neutrophil count
mri pelvis
Stanford University
 (5.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic

The purpose of this study is to investigate whether an empirically validated treatment for insomnia (CBT-I) administered early in the course of sleep disturbance can prevent insomnia disorder or lessen negative mental health outcomes in the wake of the COVID-19 crisis in adults.

insomnia
sleep disturbances
cbt-i
cognitive therapy
cognitive behavioral therapy for insomnia
Stanford University
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location